Bruns Ingmar Insider Trading -- Recent SEC Form 4 Transactions
Bruns Ingmar (CIK 1838041) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-10-01). Recent activity: Buy ZNTL (9,727 shares), Sell ZNTL (2,962 shares), Sell ZNTL (335 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-01 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Chief Medical Officer | Buy | 9,727 | $21,205 |
| 2026-02-10 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Chief Medical Officer | Sell | 2,962 | $7,198 |
| 2026-02-10 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Chief Medical Officer | Sell | 335 | $801 |
Source: SEC Form 4 filings · as of 2026-10-01